E
SFE

Ergoteles’s Safeguard Scientifics, Inc. SFE Stock Holding History

Ergoteles’s Portfolio SFE Stock Details SFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-86,300
Closed -$766K – 1685
2021
Q3 		$766K Buy
86,300
+1,274
+1% +$10.2K 0.03% 456
2021
Q2 		$660K Buy
+85,026
New +$580K 0.02% 672

Other funds holding SFE

YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
CCM
Contrarian Capital Management Greenwich, Connecticut $357M AUM 18.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CP
Clayton Partners Berkeley, California $138M AUM 38.58% 1-Year Est. Return

Ergoteles's SFE Position: Q4 2021 in Review

Ergoteles sold out of Safeguard Scientifics, Inc. (SFE) in Q4 2021, closing a stake of 86,300 shares — an estimated $766K sold.

Ergoteles first reported a position in SFE in Q2 2021 and held it in 2 quarters. The position peaked at $766K in Q3 2021. 63 funds tracked by Wall St. Rank hold SFE as of Q4 2021.

  • Ergoteles reported no remaining Safeguard Scientifics, Inc. position as of Q4 2021 after selling out during the quarter.
  • Ergoteles sold 86,300 Safeguard Scientifics, Inc. shares in Q4 2021, an estimated $766K.
  • Ergoteles first reported a position in Safeguard Scientifics, Inc. in Q2 2021 and held it in 2 quarters.
  • Ergoteles's Safeguard Scientifics, Inc. position peaked at $766K in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Safeguard Scientifics, Inc. as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.